# Tango Therapeutics, Inc.: Form 8-K, filed Mar 5, 2026

- Company: [Tango Therapeutics, Inc.](/companies/tngx.md) (CIK 1819133)
- Form: 8-K
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 5, 2026, 07:15 ET
- Period: 2026-03-05
- Accession: 0001193125-26-092535
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819133/000119312526092535/tngx-20260305.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819133/000119312526092535/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819133/000119312526092535/tngx-20260305.htm

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-092535. Last ingested by Listed: Nov 15, 2026, 01:16 ET. No prices; not investment advice.
